AstraZeneca Revenue 1992-2025 | AZN
AstraZeneca annual/quarterly revenue history and growth rate from 1992 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AstraZeneca revenue for the quarter ending June 30, 2025 was $14.457B, a 11.74% increase year-over-year.
- AstraZeneca revenue for the twelve months ending June 30, 2025 was $56.501B, a 15% increase year-over-year.
- AstraZeneca annual revenue for 2024 was $54.073B, a 18.03% increase from 2023.
- AstraZeneca annual revenue for 2023 was $45.811B, a 3.29% increase from 2022.
- AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021.
| AstraZeneca Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $54,073 |
| 2023 | $45,811 |
| 2022 | $44,351 |
| 2021 | $37,417 |
| 2020 | $26,617 |
| 2019 | $24,384 |
| 2018 | $22,090 |
| 2017 | $22,465 |
| 2016 | $23,002 |
| 2015 | $24,708 |
| 2014 | $26,547 |
| 2013 | $25,806 |
| 2012 | $27,973 |
| 2011 | $33,591 |
| 2010 | $33,269 |
| 2009 | $32,804 |
| 2008 | |